Evidence map›Paper›PMID 28167661›Full record

ArticleBlood2017

Distinct roles for TET family proteins in regulating human erythropoiesis.

Hongxia Yan, Yaomei Wang, Xiaoli Qu, Jie Li, John Hale, Yumin Huang, Chao An, Julien Papoin, Xinhua Guo, Lixiang Chen and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Macrophages in Hematopoiesis and Related Blood Diseases.Genomics, proteomics & bioinformatics · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.Journal of experimental & clinical cancer research : CR · 2022
    Review
  18. Article
  19. Analyses of erythropoiesis from embryonic stem cell-CD34Journal of cellular and molecular medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Hongxia YanLaboratory of Membrane Biology, New York Blood Center, New York, NY.
Yaomei WangLaboratory of Membrane Biology, New York Blood Center, New York, NY.
Xiaoli QuLaboratory of Membrane Biology, New York Blood Center, New York, NY.
Jie LiLaboratory of Membrane Biology, New York Blood Center, New York, NY.
John HaleRed Cell Physiology Laboratory, New York Blood Center, New York, NY.
Yumin HuangLaboratory of Membrane Biology, New York Blood Center, New York, NY.
Chao AnLaboratory of Membrane Biology, New York Blood Center, New York, NY.
Julien PapoinRed Cell Physiology Laboratory, New York Blood Center, New York, NY.
Xinhua GuoLaboratory of Membrane Biology, New York Blood Center, New York, NY.
Lixiang ChenSchool of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Qiaozhen KangSchool of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Wei LiLaboratory of Membrane Biology, New York Blood Center, New York, NY.
Vincent P SchulzDepartment of Pediatrics, and.
Patrick G GallagherDepartment of Pediatrics, and.
Christopher D HillyerRed Cell Physiology Laboratory, New York Blood Center, New York, NY.
Narla MohandasRed Cell Physiology Laboratory, New York Blood Center, New York, NY.
Xiuli AnLaboratory of Membrane Biology, New York Blood Center, New York, NY.
New York Blood Center · USZhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CNPediatrics and Genetics · USYale University · US

Funding

RED CELL DEFORMABILITY IN VITRO AND SURVIVAL IN VIVOR37DK026263 · NIDDK · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI NARLA, MOHANDAS · 1995 to 2017
$4.5M
RED CELL DEFORMABILITY IN VITRO AND SURVIVAL IN VIVOR01DK026263 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1986 to 2007
$1.6M
TET3 in Terminal Erythroid DifferentiationR01DK100810 · NIDDK · NEW YORK BLOOD CENTER · PI AN, XIULI · 2014 to 2016
$875k
NIDDK NIH HHS R01 DK026263NIDDK NIH HHS R01 DK100810NIDDK NIH HHS R37 DK026263
6 · The paper itself

Abstract

The ten-eleven translocation (TET) family of proteins plays important roles in a wide range of biological processes by oxidizing 5-methylcytosine (5mC) to 5-hydroxy-methylcytosine. However, their function in erythropoiesis has remained unclear. We show here that TET2 and TET3 but not TET1 are expressed in human erythroid cells, and we explore the role of these proteins in erythropoiesis. Knockdown experiments revealed that TET2 and TET3 have different functions. Suppression of TET3 expression in human CD34

Indexed as

Antigens, CD34DioxygenasesDNA-Binding ProteinsErythropoiesisGene Knockdown TechniquesHematopoietic Stem CellsHumansMixed Function OxygenasesMyelodysplastic SyndromesProto-Oncogene ProteinsAntigens, CD34DioxygenasesDNA-Binding ProteinsMixed Function OxygenasesProto-Oncogene ProteinsTET1 protein, humanTET2 protein, humanTET3 protein, human

Identifiers

PMID28167661
PMCPMC5383871
OpenAlexW2586900456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.